We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUL icon
451
H.B. Fuller
FUL
$3B
$22.3M 0.03%
290,005
+26,239
+10% +$2.04M
KTB icon
452
Kontoor Brands
KTB
$4.62B
$22.2M 0.03%
335,385
+205,885
+159% +$13.5M
TMO icon
453
PUT
Thermo Fisher Scientific
TMO
$211B
$22.1M 0.03%
+40,000
New +$22.9M
ADC icon
454
Agree Realty
ADC
$9.68B
$22.1M 0.03%
356,544
+189,250
+113% +$11.2M
BKLN icon
455
Invesco Senior Loan ETF
BKLN
$7.1B
$22M 0.03%
1,043,600
-1,057,100
-50% -$22.3M
TS icon
456
Tenaris
TS
$29.1B
$21.8M 0.03%
714,161
-133,628
-16% -$4.63M
VEEV icon
457
Veeva Systems
VEEV
$30.3B
$21.8M 0.03%
+118,949
New +$23.6M
INFY icon
458
Infosys
INFY
$45B
$21.7M 0.03%
1,165,514
-211,426
-15% -$3.68M
IP icon
459
CALL
International Paper
IP
$22.3B
$21.6M 0.03%
+500,000
New +$20.3M
GOGL
460
DELISTED
Golden Ocean Group
GOGL
$21.5M 0.03%
1,557,288
+766,436
+97% +$10.6M
SAP icon
461
SAP
SAP
$187B
$21.5M 0.03%
+106,487
New +$20.1M
STLA icon
462
Stellantis
STLA
$16.5B
$21.5M 0.03%
+1,082,966
New +$25.1M
VLO icon
463
Valero Energy
VLO
$89.8B
$21.4M 0.03%
136,609
-758,750
-85% -$122M
UDR icon
464
UDR
UDR
$12.9B
$21.4M 0.03%
519,219
-197,225
-28% -$7.6M
ABNB icon
465
Airbnb
ABNB
$83.7B
$21.3M 0.03%
140,273
-442,054
-76% -$67.5M
TNDM icon
466
Tandem Diabetes Care
TNDM
$1.17B
$21.1M 0.03%
524,393
-2,595,981
-83% -$108M
MDT icon
467
Medtronic
MDT
$107B
$21.1M 0.03%
267,936
+247,213
+1,193% +$20.3M
OHI icon
468
Omega Healthcare
OHI
$15.4B
$21M 0.03%
+612,022
New +$19.3M
AGO icon
469
Assured Guaranty
AGO
$3.78B
$20.9M 0.03%
271,229
-637,975
-70% -$49.9M
MRSH
470
Marsh
MRSH
$86.3B
$20.9M 0.03%
+99,100
New +$20.4M
LYV icon
471
Live Nation Entertainment
LYV
$41.2B
$20.8M 0.03%
222,326
-4,750
-2% -$449K
WDFC icon
472
WD-40
WDFC
$3.1B
$20.8M 0.03%
94,651
-11,505
-11% -$2.66M
QRVO icon
473
Qorvo
QRVO
$7.63B
$20.8M 0.03%
178,945
+76,945
+75% +$8.19M
IMNM icon
474
Immunome
IMNM
$2.52B
$20.7M 0.03%
1,713,325
+1,191,774
+229% +$18.6M
MGNI icon
475
Magnite
MGNI
$2.65B
$20.7M 0.03%
1,559,520
+578,678
+59% +$6.33M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.